These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
(Mark One)
|
/X/ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE
|
SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended March 31, 2012
|
OR
|
|
/ / TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE
|
SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from _______ to _______
|
Delaware
|
|
36-2495346
|
(State or other jurisdiction
|
|
(I.R.S. Employer
|
of incorporation or organization)
|
|
Identification Number)
|
|
|
|
251 O'Connor Ridge Blvd., Suite 300
|
|
|
Irving, Texas
|
|
75038
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Large accelerated filer
|
X
|
|
Accelerated filer
|
|
|
Non-accelerated filer
|
|
|
Smaller reporting company
|
|
|
|
|
|
|
|
(Do not check if a smaller reporting company)
|
|
|
|
|
Page No.
|
|
|
|
|
|
|
|
||
|
||
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2012 |
|
December 31,
2011 |
||||
ASSETS
|
(unaudited)
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
27,584
|
|
|
$
|
38,936
|
|
Restricted cash
|
381
|
|
|
365
|
|
||
Accounts receivable, net
|
83,373
|
|
|
95,807
|
|
||
Inventories
|
58,481
|
|
|
50,830
|
|
||
Income taxes refundable
|
6,015
|
|
|
17,042
|
|
||
Other current assets
|
9,840
|
|
|
9,235
|
|
||
Deferred income taxes
|
8,050
|
|
|
7,465
|
|
||
Total current assets
|
193,724
|
|
|
219,680
|
|
||
Property, plant and equipment, less accumulated depreciation of
$288,851 at March 31, 2012 and $278,400 at December 31, 2011
|
408,547
|
|
|
400,222
|
|
||
Intangible assets, less accumulated amortization of
$89,347 at March 31, 2012 and $82,364 at December 31, 2011
|
355,931
|
|
|
362,914
|
|
||
Goodwill
|
381,369
|
|
|
381,369
|
|
||
Investment in unconsolidated subsidiary
|
32,848
|
|
|
21,733
|
|
||
Other assets
|
29,787
|
|
|
31,112
|
|
||
|
$
|
1,402,206
|
|
|
$
|
1,417,030
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||
Current liabilities:
|
|
|
|
|
|
||
Current portion of long-term debt
|
$
|
10
|
|
|
$
|
10
|
|
Accounts payable, principally trade
|
44,078
|
|
|
60,402
|
|
||
Accrued expenses
|
59,553
|
|
|
66,845
|
|
||
Total current liabilities
|
103,641
|
|
|
127,257
|
|
||
Long-term debt, net of current portion
|
250,018
|
|
|
280,020
|
|
||
Other non-current liabilities
|
57,610
|
|
|
58,245
|
|
||
Deferred income taxes
|
34,971
|
|
|
31,133
|
|
||
Total liabilities
|
446,240
|
|
|
496,655
|
|
||
Commitments and contingencies
|
|
|
|
|
|
||
Stockholders’ equity:
|
|
|
|
|
|
||
Common stock, $0.01 par value; 150,000,000 shares authorized;
118,275,617 and 117,591,822 shares issued at March 31, 2012
and at December 31, 2011, respectively
|
1,183
|
|
|
1,176
|
|
||
Additional paid-in capital
|
595,786
|
|
|
587,685
|
|
||
Treasury stock, at cost; 665,198 and 543,384 shares at
March 31, 2012 and at December 31, 2011, respectively
|
(7,567
|
)
|
|
(5,588
|
)
|
||
Accumulated other comprehensive loss
|
(30,013
|
)
|
|
(30,904
|
)
|
||
Retained earnings
|
396,577
|
|
|
368,006
|
|
||
Total stockholders’ equity
|
955,966
|
|
|
920,375
|
|
||
|
$
|
1,402,206
|
|
|
$
|
1,417,030
|
|
|
Three Months Ended
|
||||||
|
March 31,
2012 |
|
April 2,
2011 |
||||
Net sales
|
$
|
387,108
|
|
|
$
|
439,898
|
|
Costs and expenses:
|
|
|
|
|
|
||
Cost of sales and operating expenses
|
276,469
|
|
|
301,351
|
|
||
Selling, general and administrative expenses
|
37,369
|
|
|
30,693
|
|
||
Depreciation and amortization
|
20,760
|
|
|
19,681
|
|
||
Total costs and expenses
|
334,598
|
|
|
351,725
|
|
||
Operating income
|
52,510
|
|
|
88,173
|
|
||
|
|
|
|
||||
Other expense:
|
|
|
|
|
|
||
Interest expense
|
(6,925
|
)
|
|
(14,228
|
)
|
||
Other, net
|
(608
|
)
|
|
(606
|
)
|
||
Total other expense
|
(7,533
|
)
|
|
(14,834
|
)
|
||
|
|
|
|
||||
Equity in net loss of unconsolidated subsidiary
|
(236
|
)
|
|
—
|
|
||
Income before income taxes
|
44,741
|
|
|
73,339
|
|
||
Income taxes
|
16,170
|
|
|
26,777
|
|
||
Net income
|
$
|
28,571
|
|
|
$
|
46,562
|
|
|
|
|
|
||||
Basic income per share
|
$
|
0.24
|
|
|
$
|
0.43
|
|
Diluted income per share
|
$
|
0.24
|
|
|
$
|
0.43
|
|
|
Three Months Ended
|
||||||
|
March 31, 2012
|
|
April 2, 2011
|
||||
Net income
|
$
|
28,571
|
|
|
$
|
46,562
|
|
Other comprehensive income (loss):
|
|
|
|
||||
Pension adjustments, net of tax
|
742
|
|
|
431
|
|
||
Natural gas swap derivative adjustments, net of tax
|
7
|
|
|
(39
|
)
|
||
Interest rate swap derivative adjustment, net of tax
|
142
|
|
|
195
|
|
||
Total other comprehensive income
|
891
|
|
|
587
|
|
||
Total comprehensive income
|
$
|
29,462
|
|
|
$
|
47,149
|
|
|
March 31,
2012 |
|
April 2,
2011 |
||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
28,571
|
|
|
$
|
46,562
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
||||
Depreciation and amortization
|
20,760
|
|
|
19,681
|
|
||
Loss/(gain) on disposal of property, plant, equipment and other assets
|
360
|
|
|
(40
|
)
|
||
Deferred taxes
|
3,253
|
|
|
3,422
|
|
||
Increase in long-term pension liability
|
135
|
|
|
265
|
|
||
Stock-based compensation expense
|
3,071
|
|
|
1,214
|
|
||
Write-off deferred loan costs
|
725
|
|
|
4,184
|
|
||
Deferred loan cost amortization
|
764
|
|
|
900
|
|
||
Equity in net loss of unconsolidated subsidiary
|
236
|
|
|
—
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Restricted cash
|
(16
|
)
|
|
(11
|
)
|
||
Accounts receivable
|
12,434
|
|
|
(12,370
|
)
|
||
Income taxes refundable/payable
|
11,027
|
|
|
21,802
|
|
||
Inventories and prepaid expenses
|
(8,337
|
)
|
|
(5,019
|
)
|
||
Accounts payable and accrued expenses
|
(23,438
|
)
|
|
(1,765
|
)
|
||
Other
|
4,026
|
|
|
1,875
|
|
||
Net cash provided by operating activities
|
53,571
|
|
|
80,700
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Capital expenditures
|
(24,690
|
)
|
|
(12,757
|
)
|
||
Investment in unconsolidated subsidiary
|
(11,351
|
)
|
|
(1,601
|
)
|
||
Gross proceeds from disposal of property, plant and equipment
and other assets
|
2,228
|
|
|
273
|
|
||
Net cash used by investing activities
|
(33,813
|
)
|
|
(14,085
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Payments on long-term debt
|
(30,002
|
)
|
|
(240,002
|
)
|
||
Borrowings from revolving credit facility
|
—
|
|
|
90,000
|
|
||
Payments on revolving credit facility
|
—
|
|
|
(190,000
|
)
|
||
Deferred loan costs
|
—
|
|
|
(267
|
)
|
||
Issuance of common stock
|
64
|
|
|
292,843
|
|
||
Minimum withholding taxes paid on stock awards
|
(2,157
|
)
|
|
(1,154
|
)
|
||
Excess tax benefits from stock-based compensation
|
985
|
|
|
809
|
|
||
Net cash used by financing activities
|
(31,110
|
)
|
|
(47,771
|
)
|
||
Net increase/(decrease) in cash and cash equivalents
|
(11,352
|
)
|
|
18,844
|
|
||
Cash and cash equivalents at beginning of period
|
38,936
|
|
|
19,202
|
|
||
Cash and cash equivalents at end of period
|
$
|
27,584
|
|
|
$
|
38,046
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
||||
Cash paid during the period for:
|
|
|
|
||||
Interest
|
$
|
155
|
|
|
$
|
3,579
|
|
Income taxes, net of refunds
|
$
|
295
|
|
|
$
|
1,205
|
|
(1)
|
General
|
(2)
|
Summary of Significant Accounting Policies
|
(a)
|
Basis of Presentation
|
(b)
|
Fiscal Periods
|
(c)
|
Reclassifications
|
(d)
|
Earnings Per Share
|
|
Net Income per Common Share (in thousands, except per share data)
|
||||||||||||||||||||
|
Three Months Ended
|
||||||||||||||||||||
|
|
|
March 31, 2012
|
|
|
|
|
|
April 2, 2011
|
|
|
||||||||||
|
Income
|
|
Shares
|
|
Per Share
|
|
Income
|
|
Shares
|
|
Per Share
|
||||||||||
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net Income
|
$
|
28,571
|
|
|
117,302
|
|
|
$
|
0.24
|
|
|
$
|
46,562
|
|
|
108,573
|
|
|
$
|
0.43
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Add: Option shares in the money and dilutive effect of non-vested stock
|
|
|
|
875
|
|
|
|
|
|
|
|
|
999
|
|
|
|
|
||||
Less: Pro forma treasury shares
|
|
|
|
(347
|
)
|
|
|
|
|
|
|
|
(407
|
)
|
|
|
|
||||
Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income
|
$
|
28,571
|
|
|
117,830
|
|
|
$
|
0.24
|
|
|
$
|
46,562
|
|
|
109,165
|
|
|
$
|
0.43
|
|
(3)
|
Investment in Unconsolidated Subsidiary
|
(4)
|
Contingencies
|
(5)
|
Business Segments
|
|
Three Months Ended
|
|||||
|
March 31,
2012 |
April 2,
2011 |
||||
Rendering
|
$
|
322,312
|
|
$
|
371,570
|
|
Bakery
|
64,796
|
|
68,328
|
|
||
Total
|
$
|
387,108
|
|
$
|
439,898
|
|
|
Three Months Ended
|
|||||
|
March 31, 2012
|
April 2, 2011
|
||||
Rendering
|
$
|
64,578
|
|
$
|
88,956
|
|
Bakery
|
11,052
|
|
14,968
|
|
||
Corporate Activities
|
(40,134
|
)
|
(43,134
|
)
|
||
Interest expense
|
(6,925
|
)
|
(14,228
|
)
|
||
Net Income
|
$
|
28,571
|
|
$
|
46,562
|
|
|
March 31,
2012 |
December 31,
2011 |
||||
Rendering
|
$
|
1,087,947
|
|
$
|
1,092,988
|
|
Bakery
|
167,297
|
|
165,885
|
|
||
Corporate Activities
|
146,962
|
|
158,157
|
|
||
Total
|
$
|
1,402,206
|
|
$
|
1,417,030
|
|
(6)
|
Income Taxes
|
(7)
|
Debt
|
|
March 31,
2012 |
December 31,
2011 |
||||
Senior Notes:
|
|
|
||||
8.5% Senior Notes due 2018
|
$
|
250,000
|
|
$
|
250,000
|
|
Senior Secured Credit Facilities:
|
|
|
||||
Term Loan
|
$
|
—
|
|
$
|
30,000
|
|
Revolving Credit Facility:
|
|
|
|
|
||
Maximum availability
|
$
|
415,000
|
|
$
|
415,000
|
|
Borrowings outstanding
|
—
|
|
—
|
|
||
Letters of credit issued
|
25,652
|
|
23,440
|
|
||
Availability
|
$
|
389,348
|
|
$
|
391,560
|
|
(8)
|
Stockholders' Equity
|
(9)
|
Derivatives
|
Derivatives not
Designated as
Hedges
|
Balance Sheet
|
Asset Derivatives Fair Value
|
|||||
Location
|
March 31, 2012
|
December 31, 2011
|
|||||
Heating oil swaps and options
|
Other current assets
|
$
|
49
|
|
$
|
6
|
|
|
|
|
|
||||
Total asset derivatives not designated as hedges
|
$
|
49
|
|
$
|
6
|
|
|
|
|
|
|
||||
Total asset derivatives
|
|
$
|
49
|
|
$
|
6
|
|
Derivatives Designated
|
Balance Sheet
|
Liability Derivatives Fair Value
|
|||||
as Hedges
|
Location
|
March 31, 2012
|
December 31, 2011
|
||||
Natural gas swaps
|
Accrued expenses
|
$
|
653
|
|
$
|
669
|
|
|
|
|
|
||||
Total liability derivatives designated as hedges
|
$
|
653
|
|
$
|
669
|
|
|
|
|
|
|
||||
Derivatives not
Designated as
Hedges
|
|
|
|
|
|
||
Natural gas swaps
|
Accrued expenses
|
$
|
—
|
|
$
|
143
|
|
Heating oil swaps
|
Accrued expenses
|
4
|
|
24
|
|
||
|
|
|
|
||||
Total liability derivatives not designated as hedges
|
$
|
4
|
|
$
|
167
|
|
|
|
|
|
|
||||
Total liability derivatives
|
$
|
657
|
|
$
|
836
|
|
Derivatives
Designated as
Cash Flow Hedges
|
Gain or (Loss)
Recognized in OCI
on Derivatives
(Effective Portion) (a)
|
Gain or (Loss)
Reclassified From
Accumulated OCI
into Income
(Effective Portion) (b)
|
Gain or (Loss)
Recognized in Income
on Derivatives
(Ineffective Portion and
Amount Excluded from
Effectiveness Testing) (c)
|
|||||||||||||||
|
2012
|
2011
|
2012
|
2011
|
2012
|
2011
|
||||||||||||
Interest rate swaps
|
$
|
—
|
|
$
|
—
|
|
$
|
(232
|
)
|
$
|
(319
|
)
|
$
|
—
|
|
$
|
—
|
|
Natural gas swaps
|
(700
|
)
|
(213
|
)
|
(713
|
)
|
(150
|
)
|
3
|
|
8
|
|
||||||
|
|
|
|
|
|
|
||||||||||||
Total
|
$
|
(700
|
)
|
$
|
(213
|
)
|
$
|
(945
|
)
|
$
|
(469
|
)
|
$
|
3
|
|
$
|
8
|
|
(a)
|
Amount recognized in accumulated OCI (effective portion) is reported as accumulated other comprehensive income/(loss) of approximately $
0.7 million
and approximately $
0.2 million
recorded net of taxes of approximately $
0.3 million
and approximately $
0.1 million
as of
March 31, 2012
and
April 2, 2011
, respectively.
|
(b)
|
Gains and (losses) reclassified from accumulated OCI into income (effective portion) for interest rate swaps and natural gas swaps is included in interest expense and cost of sales, respectively, in the Company’s consolidated statements of operations.
|
(c)
|
Gains and (losses) recognized in income on derivatives (ineffective portion) for interest rate swaps and natural gas swaps is included in other, net in the Company’s consolidated statements of operations.
|
(11)
|
Comprehensive Income
|
|
Before-Tax
|
|
Tax (Expense)
|
|
Net-of-Tax
|
|||||||||||||||
|
Amount
|
|
or Benefit
|
|
Amount
|
|||||||||||||||
|
March 31,
2012 |
April 2,
2011 |
|
March 31,
2012 |
April 2,
2011 |
|
March 31,
2012 |
April 2,
2011 |
||||||||||||
Defined benefit pension plans
|
|
|
|
|
|
|
|
|
||||||||||||
Amortization of prior service cost
|
$
|
22
|
|
$
|
22
|
|
|
$
|
(8
|
)
|
$
|
(8
|
)
|
|
$
|
14
|
|
$
|
14
|
|
Amortization of actuarial loss
|
1,189
|
|
681
|
|
|
(461
|
)
|
(264
|
)
|
|
728
|
|
417
|
|
||||||
Total defined benefit pension plans
|
1,211
|
|
703
|
|
|
(469
|
)
|
(272
|
)
|
|
742
|
|
431
|
|
||||||
|
|
|
|
|
|
|
|
|
||||||||||||
Natural gas swap derivatives
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Loss reclassified to net income
|
713
|
|
150
|
|
|
(276
|
)
|
(58
|
)
|
|
437
|
|
92
|
|
||||||
Loss activity recognized in other comprehensive loss
|
(700
|
)
|
(213
|
)
|
|
270
|
|
82
|
|
|
(430
|
)
|
(131
|
)
|
||||||
Total natural gas swap derivatives
|
13
|
|
(63
|
)
|
|
(6
|
)
|
24
|
|
|
7
|
|
(39
|
)
|
||||||
|
|
|
|
|
|
|
|
|
||||||||||||
Interest rate swap derivatives
|
|
|
|
|
|
|
|
|
||||||||||||
Loss reclassified to net income
|
232
|
|
319
|
|
|
(90
|
)
|
(124
|
)
|
|
142
|
|
195
|
|
||||||
|
|
|
|
|
|
|
|
|
||||||||||||
Other Comprehensive income (loss)
|
$
|
1,456
|
|
$
|
959
|
|
|
$
|
(565
|
)
|
$
|
(372
|
)
|
|
$
|
891
|
|
$
|
587
|
|
|
Three Months Ended
|
|||||
|
March 31,
2012 |
April 2,
2011 |
||||
Service cost
|
$
|
81
|
|
$
|
295
|
|
Interest cost
|
1,363
|
|
1,513
|
|
||
Expected return on plan assets
|
(1,677
|
)
|
(1,722
|
)
|
||
Amortization of prior service cost
|
22
|
|
22
|
|
||
Amortization of net loss
|
1,189
|
|
681
|
|
||
Net pension cost
|
$
|
978
|
|
$
|
789
|
|
|
|
Fair Value Measurements at March 31, 2012 Using
|
||||||||||
|
|
Quoted Prices in
Active Markets for
Identical Assets
|
Significant Other
Observable
Inputs
|
Significant
Unobservable
Inputs
|
||||||||
(In thousands of dollars)
|
Total
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
||||||||
Assets:
|
|
|
|
|
||||||||
Derivative instruments
|
$
|
49
|
|
$
|
—
|
|
$
|
49
|
|
$
|
—
|
|
Total Assets
|
$
|
49
|
|
$
|
—
|
|
$
|
49
|
|
$
|
—
|
|
|
|
|
|
|
||||||||
Liabilities:
|
|
|
|
|
||||||||
Derivative instruments
|
$
|
657
|
|
$
|
—
|
|
$
|
657
|
|
$
|
—
|
|
Senior Notes
|
278,750
|
|
—
|
|
278,750
|
|
—
|
|
||||
Total Liabilities
|
$
|
279,407
|
|
$
|
—
|
|
$
|
279,407
|
|
$
|
—
|
|
|
Issuer
|
Guarantors
|
Non-guarantors
|
Eliminations
|
Consolidated
|
||||||||||
ASSETS
|
|
|
|
|
|
||||||||||
Total current assets
|
$
|
101,566
|
|
$
|
366,530
|
|
$
|
2,183
|
|
$
|
(276,555
|
)
|
$
|
193,724
|
|
Investment in subsidiaries
|
1,327,883
|
|
—
|
|
—
|
|
(1,327,883
|
)
|
—
|
|
|||||
Property, plant and equipment, net
|
121,893
|
|
286,654
|
|
—
|
|
—
|
|
408,547
|
|
|||||
Intangible assets, net
|
14,080
|
|
341,564
|
|
287
|
|
—
|
|
355,931
|
|
|||||
Goodwill
|
21,860
|
|
359,243
|
|
266
|
|
—
|
|
381,369
|
|
|||||
Investment in unconsolidated subsidiary
|
—
|
|
—
|
|
32,848
|
|
—
|
|
32,848
|
|
|||||
Other assets
|
26,168
|
|
3,619
|
|
—
|
|
—
|
|
29,787
|
|
|||||
|
$
|
1,613,450
|
|
$
|
1,357,610
|
|
$
|
35,584
|
|
$
|
(1,604,438
|
)
|
$
|
1,402,206
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
|||||||
Total current liabilities
|
$
|
327,136
|
|
$
|
52,039
|
|
$
|
1,021
|
|
$
|
(276,555
|
)
|
$
|
103,641
|
|
Long-term debt, net of current portion
|
250,000
|
|
18
|
|
—
|
|
—
|
|
250,018
|
|
|||||
Other noncurrent liabilities
|
45,377
|
|
12,052
|
|
181
|
|
—
|
|
57,610
|
|
|||||
Deferred income taxes
|
34,971
|
|
—
|
|
—
|
|
—
|
|
34,971
|
|
|||||
Total liabilities
|
657,484
|
|
64,109
|
|
1,202
|
|
(276,555
|
)
|
446,240
|
|
|||||
Stockholders’ equity:
|
|
|
|
|
|
|
|
|
|||||||
Common stock, additional paid-in capital and treasury stock
|
589,402
|
|
1,022,544
|
|
39,358
|
|
(1,061,902
|
)
|
589,402
|
|
|||||
Retained earnings and accumulated other comprehensive loss
|
366,564
|
|
270,957
|
|
(4,976
|
)
|
(265,981
|
)
|
366,564
|
|
|||||
Total stockholders’ equity
|
955,966
|
|
1,293,501
|
|
34,382
|
|
(1,327,883
|
)
|
955,966
|
|
|||||
|
$
|
1,613,450
|
|
$
|
1,357,610
|
|
$
|
35,584
|
|
$
|
(1,604,438
|
)
|
$
|
1,402,206
|
|
|
Issuer
|
Guarantors
|
Non-guarantors
|
Eliminations
|
Consolidated
|
||||||||||
ASSETS
|
|
|
|
|
|
||||||||||
Total current assets
|
$
|
124,675
|
|
$
|
347,989
|
|
$
|
3,980
|
|
$
|
(256,964
|
)
|
$
|
219,680
|
|
Investment in subsidiaries
|
1,286,175
|
|
—
|
|
—
|
|
(1,286,175
|
)
|
—
|
|
|||||
Property, plant and equipment, net
|
119,898
|
|
280,324
|
|
—
|
|
—
|
|
400,222
|
|
|||||
Intangible assets, net
|
14,747
|
|
347,874
|
|
293
|
|
—
|
|
362,914
|
|
|||||
Goodwill
|
21,860
|
|
359,243
|
|
266
|
|
—
|
|
381,369
|
|
|||||
Investment in unconsolidated subsidiary
|
—
|
|
—
|
|
21,733
|
|
—
|
|
21,733
|
|
|||||
Other assets
|
27,725
|
|
3,387
|
|
—
|
|
—
|
|
31,112
|
|
|||||
|
$
|
1,595,080
|
|
$
|
1,338,817
|
|
$
|
26,272
|
|
$
|
(1,543,139
|
)
|
$
|
1,417,030
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
|||||||
Total current liabilities
|
$
|
317,561
|
|
$
|
63,718
|
|
$
|
2,942
|
|
$
|
(256,964
|
)
|
$
|
127,257
|
|
Long-term debt, net of current portion
|
280,000
|
|
20
|
|
—
|
|
—
|
|
280,020
|
|
|||||
Other noncurrent liabilities
|
46,011
|
|
12,052
|
|
182
|
|
—
|
|
58,245
|
|
|||||
Deferred income taxes
|
31,133
|
|
—
|
|
—
|
|
—
|
|
31,133
|
|
|||||
Total liabilities
|
674,705
|
|
75,790
|
|
3,124
|
|
(256,964
|
)
|
496,655
|
|
|||||
Stockholders’ equity:
|
|
|
|
|
|
|
|
|
|||||||
Common stock, additional paid-in capital and treasury stock
|
583,273
|
|
1,022,544
|
|
27,982
|
|
(1,050,526
|
)
|
583,273
|
|
|||||
Retained earnings and accumulated other comprehensive loss
|
337,102
|
|
240,483
|
|
(4,834
|
)
|
(235,649
|
)
|
337,102
|
|
|||||
Total stockholders’ equity
|
920,375
|
|
1,263,027
|
|
23,148
|
|
(1,286,175
|
)
|
920,375
|
|
|||||
|
$
|
1,595,080
|
|
$
|
1,338,817
|
|
$
|
26,272
|
|
$
|
(1,543,139
|
)
|
$
|
1,417,030
|
|
|
Issuer
|
Guarantors
|
Non-guarantors
|
Eliminations
|
Consolidated
|
||||||||||
Net sales
|
$
|
152,988
|
|
$
|
273,509
|
|
$
|
2,554
|
|
$
|
(41,943
|
)
|
$
|
387,108
|
|
Cost and expenses:
|
|
|
|
|
|
||||||||||
Cost of sales and operating expenses
|
121,097
|
|
194,813
|
|
2,502
|
|
(41,943
|
)
|
276,469
|
|
|||||
Selling, general and administrative expenses
|
20,785
|
|
16,545
|
|
39
|
|
—
|
|
37,369
|
|
|||||
Depreciation and amortization
|
6,296
|
|
14,458
|
|
6
|
|
—
|
|
20,760
|
|
|||||
Total costs and expenses
|
148,178
|
|
225,816
|
|
2,547
|
|
(41,943
|
)
|
334,598
|
|
|||||
Operating income
|
4,810
|
|
47,693
|
|
7
|
|
—
|
|
52,510
|
|
|||||
|
|
|
|
|
|
|
|
|
|||||||
Interest expense
|
(6,925
|
)
|
—
|
|
—
|
|
—
|
|
(6,925
|
)
|
|||||
Other, net
|
(642
|
)
|
27
|
|
7
|
|
—
|
|
(608
|
)
|
|||||
Equity in net loss of unconsolidated subsidiary
|
—
|
|
—
|
|
(236
|
)
|
—
|
|
(236
|
)
|
|||||
Earnings in investments in subsidiaries
|
30,332
|
|
—
|
|
—
|
|
(30,332
|
)
|
—
|
|
|||||
Income/(loss) before taxes
|
27,575
|
|
47,720
|
|
(222
|
)
|
(30,332
|
)
|
44,741
|
|
|||||
Income taxes (Benefit)
|
(996
|
)
|
17,246
|
|
(80
|
)
|
—
|
|
16,170
|
|
|||||
Net income (loss)
|
$
|
28,571
|
|
$
|
30,474
|
|
$
|
(142
|
)
|
$
|
(30,332
|
)
|
$
|
28,571
|
|
|
|
|
|
|
|
|
Issuer
|
Guarantors
|
Non-guarantors
|
Eliminations
|
Consolidated
|
||||||||||
Net sales
|
$
|
174,655
|
|
$
|
307,114
|
|
$
|
6,549
|
|
$
|
(48,420
|
)
|
$
|
439,898
|
|
Cost and expenses:
|
|
|
|
|
|
||||||||||
Cost of sales and operating expenses
|
131,988
|
|
211,525
|
|
6,257
|
|
(48,419
|
)
|
301,351
|
|
|||||
Selling, general and administrative expenses
|
15,187
|
|
15,466
|
|
40
|
|
—
|
|
30,693
|
|
|||||
Depreciation and amortization
|
6,184
|
|
13,497
|
|
—
|
|
—
|
|
19,681
|
|
|||||
Total costs and expenses
|
153,359
|
|
240,488
|
|
6,297
|
|
(48,419
|
)
|
351,725
|
|
|||||
Operating income
|
21,296
|
|
66,626
|
|
252
|
|
(1
|
)
|
88,173
|
|
|||||
|
|
|
|
|
|
|
|
|
|||||||
Interest expense
|
(14,227
|
)
|
(1
|
)
|
—
|
|
—
|
|
(14,228
|
)
|
|||||
Other, net
|
(524
|
)
|
(76
|
)
|
(7
|
)
|
1
|
|
(606
|
)
|
|||||
Earnings in investments in subsidiaries
|
42,407
|
|
—
|
|
—
|
|
(42,407
|
)
|
—
|
|
|||||
Income/(loss) before taxes
|
48,952
|
|
66,549
|
|
245
|
|
(42,407
|
)
|
73,339
|
|
|||||
Income taxes
|
2,390
|
|
24,297
|
|
90
|
|
—
|
|
26,777
|
|
|||||
Net income (loss)
|
$
|
46,562
|
|
$
|
42,252
|
|
$
|
155
|
|
$
|
(42,407
|
)
|
$
|
46,562
|
|
|
|
|
|
|
|
|
Issuer
|
Guarantors
|
Non-guarantors
|
Eliminations
|
Consolidated
|
||||||||||
Net income
|
$
|
28,571
|
|
$
|
30,474
|
|
$
|
(142
|
)
|
$
|
(30,332
|
)
|
$
|
28,571
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
||||||||||
Pension adjustments, net of tax
|
742
|
|
—
|
|
—
|
|
—
|
|
742
|
|
|||||
Natural gas swap derivative adjustments, net of tax
|
7
|
|
—
|
|
—
|
|
—
|
|
7
|
|
|||||
Interest rate swap derivative adjustment, net of tax
|
142
|
|
—
|
|
—
|
|
—
|
|
142
|
|
|||||
Total other comprehensive income (loss)
|
891
|
|
—
|
|
—
|
|
—
|
|
891
|
|
|||||
Total comprehensive income (loss)
|
$
|
29,462
|
|
$
|
30,474
|
|
$
|
(142
|
)
|
$
|
(30,332
|
)
|
$
|
29,462
|
|
|
Issuer
|
Guarantors
|
Non-guarantors
|
Eliminations
|
Consolidated
|
||||||||||
Net income
|
$
|
46,562
|
|
$
|
42,252
|
|
$
|
155
|
|
$
|
(42,407
|
)
|
$
|
46,562
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
||||||||||
Pension adjustments, net of tax
|
431
|
|
—
|
|
—
|
|
—
|
|
431
|
|
|||||
Natural gas swap derivative adjustments, net of tax
|
(39
|
)
|
—
|
|
—
|
|
—
|
|
(39
|
)
|
|||||
Interest rate swap derivative adjustment, net of tax
|
195
|
|
—
|
|
—
|
|
—
|
|
195
|
|
|||||
Total other comprehensive income (loss)
|
587
|
|
—
|
|
—
|
|
—
|
|
587
|
|
|||||
Total comprehensive income (loss)
|
$
|
47,149
|
|
$
|
42,252
|
|
$
|
155
|
|
$
|
(42,407
|
)
|
$
|
47,149
|
|
|
Issuer
|
Guarantors
|
Non-guarantors
|
Eliminations
|
Consolidated
|
||||||||||
Cash flows from operating activities:
|
|
|
|
|
|
||||||||||
Net income
|
$
|
28,571
|
|
$
|
30,474
|
|
$
|
(142
|
)
|
$
|
(30,332
|
)
|
$
|
28,571
|
|
Earnings in investments in subsidiaries
|
(30,332
|
)
|
—
|
|
—
|
|
30,332
|
|
—
|
|
|||||
Other operating cash flows
|
31,598
|
|
(16,795
|
)
|
10,197
|
|
—
|
|
25,000
|
|
|||||
Net cash provided by operating activities
|
29,837
|
|
13,679
|
|
10,055
|
|
—
|
|
53,571
|
|
|||||
|
|
|
|
|
|
||||||||||
Cash flows from investing activities:
|
|
|
|
|
|
||||||||||
Capital expenditures
|
(8,123
|
)
|
(16,567
|
)
|
—
|
|
—
|
|
(24,690
|
)
|
|||||
Investment in unconsolidated subsidiary
|
—
|
|
—
|
|
(11,351
|
)
|
—
|
|
(11,351
|
)
|
|||||
Gross proceeds from sale of property, plant and equipment and other assets
|
1,111
|
|
1,117
|
|
—
|
|
—
|
|
2,228
|
|
|||||
Net cash used in investing activities
|
(7,012
|
)
|
(15,450
|
)
|
(11,351
|
)
|
—
|
|
(33,813
|
)
|
|||||
|
|
|
|
|
|
||||||||||
Cash flows from financing activities:
|
|
|
|
|
|
||||||||||
Payments on long-term debt
|
(30,000
|
)
|
(2
|
)
|
—
|
|
—
|
|
(30,002
|
)
|
|||||
Issuances of common stock
|
64
|
|
—
|
|
—
|
|
—
|
|
64
|
|
|||||
Minimum withholding taxes paid on stock awards
|
(2,157
|
)
|
—
|
|
—
|
|
—
|
|
(2,157
|
)
|
|||||
Excess tax benefits from stock-based compensation
|
985
|
|
—
|
|
—
|
|
—
|
|
985
|
|
|||||
Net cash used in financing activities
|
(31,108
|
)
|
(2
|
)
|
—
|
|
—
|
|
(31,110
|
)
|
|||||
|
|
|
|
|
|
||||||||||
Net decrease in cash and cash equivalents
|
(8,283
|
)
|
(1,773
|
)
|
(1,296
|
)
|
—
|
|
(11,352
|
)
|
|||||
Cash and cash equivalents at beginning of year
|
35,207
|
|
1,773
|
|
1,956
|
|
—
|
|
38,936
|
|
|||||
Cash and cash equivalents at end of year
|
$
|
26,924
|
|
$
|
—
|
|
$
|
660
|
|
$
|
—
|
|
$
|
27,584
|
|
|
Issuer
|
Guarantors
|
Non-guarantors
|
Eliminations
|
Consolidated
|
||||||||||
Cash flows from operating activities:
|
|
|
|
|
|
||||||||||
Net income
|
$
|
46,562
|
|
$
|
42,252
|
|
$
|
155
|
|
$
|
(42,407
|
)
|
$
|
46,562
|
|
Earnings in investments in subsidiaries
|
(42,407
|
)
|
—
|
|
—
|
|
42,407
|
|
—
|
|
|||||
Other operating cash flows
|
65,061
|
|
(32,202
|
)
|
1,279
|
|
—
|
|
34,138
|
|
|||||
Net cash provided by operating activities
|
69,216
|
|
10,050
|
|
1,434
|
|
—
|
|
80,700
|
|
|||||
|
|
|
|
|
|
||||||||||
Cash flows from investing activities:
|
|
|
|
|
|
||||||||||
Capital expenditures
|
(5,047
|
)
|
(7,710
|
)
|
—
|
|
—
|
|
(12,757
|
)
|
|||||
Investment in unconsolidated subsidiary
|
—
|
|
—
|
|
(1,601
|
)
|
—
|
|
(1,601
|
)
|
|||||
Gross proceeds from sale of property, plant and equipment and other assets
|
198
|
|
75
|
|
—
|
|
—
|
|
273
|
|
|||||
Net cash used in investing activities
|
(4,849
|
)
|
(7,635
|
)
|
(1,601
|
)
|
—
|
|
(14,085
|
)
|
|||||
|
|
|
|
|
|
||||||||||
Cash flows from financing activities:
|
|
|
|
|
|
||||||||||
Payments on long-term debt
|
(240,000
|
)
|
(2
|
)
|
—
|
|
—
|
|
(240,002
|
)
|
|||||
Borrowings from revolving credit facility
|
90,000
|
|
—
|
|
—
|
|
—
|
|
90,000
|
|
|||||
Payments on revolving credit facility
|
(190,000
|
)
|
—
|
|
—
|
|
—
|
|
(190,000
|
)
|
|||||
Deferred loan costs
|
(267
|
)
|
—
|
|
—
|
|
—
|
|
(267
|
)
|
|||||
Issuances of common stock
|
292,843
|
|
—
|
|
—
|
|
—
|
|
292,843
|
|
|||||
Minimum withholding taxes paid on stock awards
|
(1,154
|
)
|
—
|
|
—
|
|
—
|
|
(1,154
|
)
|
|||||
Excess tax benefits from stock-based compensation
|
809
|
|
—
|
|
—
|
|
—
|
|
809
|
|
|||||
Net cash used in financing activities
|
(47,769
|
)
|
(2
|
)
|
—
|
|
—
|
|
(47,771
|
)
|
|||||
|
|
|
|
|
|
||||||||||
Net increase/(decrease) in cash and cash equivalents
|
16,598
|
|
2,413
|
|
(167
|
)
|
—
|
|
18,844
|
|
|||||
Cash and cash equivalents at beginning of year
|
13,108
|
|
5,480
|
|
614
|
|
—
|
|
19,202
|
|
|||||
Cash and cash equivalents at end of year
|
$
|
29,706
|
|
$
|
7,893
|
|
$
|
447
|
|
$
|
—
|
|
$
|
38,046
|
|
•
|
Lower finished product prices for MBM, BFT, PG, YG and BPP as compared to the first quarter of
fiscal 2011
is a sign of decreased demand due to a slowdown in the domestic and international markets. These lower prices were partially offset by an overall increase in average PM (both feed grade and pet food grade) prices. Overall, finished product prices were unfavorable to the Company's sales revenue, but this unfavorable result was partially offset by the positive impact on raw material cost, due to the Company's formula pricing arrangements with raw material suppliers, which index raw material cost to the prices of finished product derived from the raw material. The financial impact of finished goods prices on sales revenue and raw material cost is summarized below in Results of Operations. Comparative sales price information from the Jacobsen index, an established trading exchange publisher used by management to monitor performance, is provided below in Summary of Key Indicators.
|
•
|
Lower raw material volumes were collected from suppliers during the first quarter of
fiscal 2012
as compared to the first quarter of
fiscal 2011
. Management believes the decline in raw material volume is due to weaker slaughter and processor rates resulting from a slowdown of the economy that contributed to a decline in raw material volumes collected by the Company during the quarter. The financial impact of lower raw material volumes is summarized below in Results of Operations.
|
•
|
Energy prices for natural gas decreased and diesel fuel decreased slightly during the first quarter of
fiscal 2012
as compared to the first quarter of
fiscal 2011
. The financial impact of energy costs is summarized below in Results of Operations.
|
•
|
The Company collected lower raw material volumes due to the slowdown of the economy resulting in weaker slaughter and processor rates in the first quarter of fiscal 2012. If this reduction continues or accelerates, there could be a negative impact on the Company's ability to obtain raw materials for the Company's operation.
|
•
|
Finished product prices for MBM, BFT, PG, YG and BBP commodities have decreased during the first quarter of fiscal 2012 as compared to the same period of fiscal 2011. No assurance can be given that this decrease in commodity prices for various proteins, fats and bakery products will not continue in the future, as commodity prices are volatile by their nature. A further decrease in commodity prices could have a significant impact on the Company’s earnings for the remainder of fiscal 2012 and into future periods.
|
•
|
The Company consumes significant volumes of natural gas to operate boilers in its plants, which generate steam to heat raw material. Natural gas prices represent a significant cost of factory operation included in cost of sales. The Company also consumes significant volumes of diesel fuel to operate its fleet of tractors and trucks used to collect raw material. Diesel fuel prices represent a significant component of cost of collection expenses included in cost of sales. Lower natural gas and diesel fuel prices were incurred during the first quarter of fiscal 2012 as compared to the same period of fiscal 2011. These prices can be volatile and there can be no assurance that these prices will not increase in the near future, thereby representing an ongoing challenge to the Company’s operating results for future periods. A material increase in energy prices for natural gas and/or diesel fuel over a sustained period of time could materially adversely affect the Company’s business, financial condition and results of operations.
|
•
|
Pursuant to the requirements established by the Energy Independence and Security Act of 2007, on February 3, 2010 the EPA finalized regulations for the National Renewable Fuel Standard Program (“RFS2”). The regulation mandates the domestic use of biomass-based diesel (biodiesel or renewable diesel) of 1.0 billion gallons in 2012. Beyond 2012 the regulation requires a minimum of 1.0 billion gallons of biomass-based diesel for each year through 2022, which amount is subject to increase by the EPA Administrator. On June 20, 2011, the EPA issued a proposed rule which would require 1.28 billion gallons for the calendar year 2013. Biomass-based diesel also qualifies to fulfill the non-specified portion of the advanced bio-fuel requirement. In order to qualify as a “renewable fuel” each type of fuel from each type of feedstock is required to lower greenhouse gas emissions (“GHG”) by levels specified in the regulation. The EPA has determined that bio-fuels (either biodiesel or renewable diesel) produced from waste oils, fats and greases result in an 86% reduction in GHG emissions, exceeding the 50% requirement established by the regulation. Prices for the Company’s finished products may be impacted by worldwide government policies relating to renewable fuels and GHG. Programs like RFS2 and tax credits for bio-fuels both in the U.S. and abroad may positively impact the demand for the Company’s finished products. Accordingly, changes to, a failure to enforce or discontinuing of any of these programs could have a negative impact on the Company’s business and results of operations.
|
•
|
The Company’s exports are subject to the imposition of tariffs, quotas, trade barriers and other trade protection measures imposed by foreign countries regarding the import of the Company’s MBM, BFT and YG. General economic and political conditions as well as the closing of borders by foreign countries to the import of the Company’s products due to animal disease or other perceived health or safety issues impact the Company. As a result trade policies of both U.S and foreign countries could have a negative impact on the Company’s business and results of operations.
|
•
|
Effective August 1997, the FDA promulgated a rule prohibiting the use of mammalian proteins, with some exceptions, in feeds for cattle, sheep and other ruminant animals (referred to herein as the “BSE Feed Rule”) to prevent further spread of BSE, commonly referred to as “mad cow disease.” Detection of the first case of BSE in the United States in December 2003 resulted in additional U.S. government regulations, finished product export restrictions by foreign governments, market price fluctuations for the Company's finished products and reduced demand for beef and beef products by consumers. Even though the export markets for U.S. beef rebounded to record volumes in fiscal 2011 that exceeded pre-BSE levels, most export markets remain closed to MBM derived from U.S. beef. On April 24, 2012, the United States Department of Agriculture (“USDA”) confirmed the occurrence of a new, single case of BSE in a dairy cow in central California. Even though the USDA confirmed that material derived from the cow did not enter the food or feed supply and that this appears to be a single, isolated incident of "atypical" BSE
which is not spread through feed and does not affect humans, Indonesia closed its markets to MBM derived from U.S. beef, and those markets remain closed as of the filing date of this Report. The Company does not expect this trade disruption to have material impact on the Company's business, financial condition or results of operations. Continued concern about BSE in the United States may result in additional regulatory and market related challenges that may affect the Company's operations or increase the Company's operating costs.
|
•
|
With respect to BSE in the United States, on October 26, 2009, the FDA began enforcing new regulations intended to further reduce the risk of spreading BSE (“Enhanced BSE Rule”). These new regulations included amending the BSE Feed Rule to prohibit the use of tallow having more than 0.15% insoluble impurities in feed for cattle or other ruminant animals. In addition, the FDA implemented rules that prohibit the use of brain and spinal cord material from cattle aged 30 months and older or the carcasses of such cattle, if the brain and spinal cord are not removed, in the feed or food for all animals (“Prohibited Cattle Materials”). Tallow derived from Prohibited Cattle Materials that also contains more than 0.15% insoluble impurities cannot be fed to any animal. The Company has followed the Enhanced BSE Rule since it was first published in 2008 and has made capital expenditures and implemented new processes and procedures to be compliant with the Enhanced BSE Rule at all of the Company's operations. Based on the foregoing, while the Company acknowledges that unanticipated issues may arise as the FDA continues to implement the Enhanced BSE Rule and conducts compliance inspections, the Company does not currently anticipate that the Enhanced BSE Rule will have a significant impact on the Company operations or financial performance. Notwithstanding the foregoing, the Company can provide no assurance that unanticipated costs and/or reductions in raw material volumes related to the Company's compliance with the Enhanced BSE Rule will not negatively impact the Company's operations and financial performance.
|
•
|
With respect to human food, pet food and animal feed safety, the Food and Drug Administration Amendments Act of 2007 (the “FDAAA”) was signed into law on September 27, 2007 as a result of Congressional concern for pet and livestock food safety, following the discovery in March 2007 of pet and livestock food that contained adulterated imported ingredients. The FDAAA directs the Secretary of Health and Human Services and the FDA to promulgate significant new requirements for the pet food and animal feed industries. As a prerequisite to new requirements specified by the FDAAA, the FDA was directed to establish a Reportable Food Registry, which was implemented on September 8, 2009. On June 11, 2009, the FDA issued “Guidance for Industry: Questions and Answers Regarding the Reportable Food Registry as Established by the Food and Drug Administration Amendments Act of 2007: Draft Guidance.” Stakeholder comments and questions about the Reportable Food Registry that were submitted to the docket or during public meetings were incorporated into a second draft guidance (“RFR Draft Guidance”), which was published on September 8, 2009. In the RFR Draft Guidance, the FDA defined a reportable food, which the manufacturer or distributor would be required to report in the Reportable Food Registry, to include materials used as ingredients in animal feeds and pet foods, if there is reasonable probability that the use of such materials will cause serious adverse health consequences or death to humans or animals. The FDA issued a second version of its RFR Draft Guidance in May 2010 without finalizing it. On July 27, 2010, the FDA released “Compliance Policy guide Sec. 690.800,
Salmonella
in Animal Feed, Draft Guidance” (“Draft CPG”), which describes differing criteria to determine whether pet food and farmed animal feeds that are contaminated with salmonella will be considered to be adulterated under section 402(a)(1) of the Food Drug and Cosmetic Act. According to the Draft CPG, any finished pet food contaminated with any species of salmonella will be considered adulterated because such feeds have direct human contact. Finished animal feeds intended for pigs, poultry and other farmed animals, however, will be considered to be adulterated only if the feed is contaminated with a species of salmonella that is considered to be pathogenic for the animal species that the feed is intended for. The impact of the FDAAA and implementation of the Reportable Food Registry on the Company, if any, will not be clear until the FDA finalizes its RFR Draft Guidance and the Draft CPG, neither of which were finalized as of the date of this report. The Company believes that it has adequate procedures in place to assure that its finished products are safe to use in animal feed and pet food and the
|
•
|
In addition, on January 4, 2011, President Barack Obama signed the Food Safety Modernization Act (“FSMA”) into law. As enacted, the FSMA gave the FDA new authorities, which became effective immediately. Included among these is mandatory recall authority for adulterated foods that are likely to cause serious adverse health consequences or death to humans or animals, if the responsible party fails to cease distribution and recall such adulterated foods voluntarily. The FSMA further instructed the FDA to amend existing regulations that define its administrative detention authority so that the criteria needed for detaining human or animal food are lowered. Prior to the FSMA becoming law, FDA had authority to order that an article of food be detained only if there was credible evidence or information indicating that the article of food presented a threat of serious adverse health consequences or death to humans or animals. On May 5, 2011, FDA issued an interim final rule amending its administrative detention authority and lowering both the level of proof and the degree of risk required for detaining an article of food. This interim final rule, which became effective on July 3, 2011, gives the FDA authority to detain an article of food if there is reason to believe the food is adulterated or misbranded. In addition to amending existing regulations, the FSMA requires the FDA to develop new regulations that, among other provisions, place additional registration requirements on food and feed producing firms; require registered facilities to perform hazard analysis and to implement preventive plans to control those hazards identified to be reasonably likely to occur; increase the length of time that records are required to be retained; and regulate the sanitary transportation of food. Such new food safety provisions will require new FDA rule making. The Company has followed the FSMA throughout its legislative history and implemented hazard prevention controls and other procedures that the Company believes will be needed to comply with the FSMA. Such rule-making could, among other things, require the Company to amend certain of the Company's other operational policies and procedures. While unforeseen issues and requirements may arise as the FDA promulgates the new regulations provided for by the FSMA, the Company does not anticipate that the costs of compliance with the FSMA will materially impact the Company's business or operations.
|
•
|
The emergence of diseases such as 2009 H1N1 flu (initially know as “Swine Flu”) and H5N1 avian influenza (“Bird Flu”) that are in or associated with animals and have the potential to also threaten humans has created concern that such diseases could spread and cause a global pandemic. Even though such a pandemic has not occurred, governments may be pressured to address these concerns and prohibit imports of animals, meat and animal by-products from countries or regions where the disease is detected. The occurrence of Swine Flu, Bird Flu or any other disease in the United States that is correctly or incorrectly linked to animals and has a negative impact on meat or poultry consumption or animal production could have a material negative impact on the volume of raw materials available to the Company or the demand for the Company's finished products.
|
•
|
Finished product commodity prices,
|
•
|
Raw material volume,
|
•
|
Production volume and related yield of finished product,
|
•
|
Energy prices for natural gas quoted on the NYMEX index and diesel fuel,
|
•
|
Collection fees and collection operating expense, and
|
•
|
Factory operating expenses.
|
|
Avg. Price
1st Quarter
2012
|
Avg. Price
1st Quarter
2011
|
Increase/(Decrease)
|
%
Increase/(Decrease)
|
|
Rendering Segment:
|
|
|
|
|
|
MBM (Illinois)
|
$ 315.56/ton
|
$ 335.81/ton
|
$ (20.25)/ton
|
(6.0
|
)%
|
Feed Grade PM (Carolina)
|
$ 386.51/ton
|
$ 360.24/ton
|
$ 26.27/ton
|
7.3
|
%
|
Pet Food PM (Southeast)
|
$ 658.93/ton
|
$ 563.93/ton
|
$ 95.00/ton
|
16.8
|
%
|
BFT (Chicago)
|
$ 46.06/cwt
|
$ 48.14/cwt
|
$ (2.08)/cwt
|
(4.3
|
)%
|
PG (Southeast)
|
$ 44.03/cwt
|
$ 44.89/cwt
|
$ (0.86)/cwt
|
(1.9
|
)%
|
YG (Illinois)
|
$ 38.83/cwt
|
$ 42.40/cwt
|
$ (3.57)/cwt
|
(8.4
|
)%
|
Bakery Segment:
|
|
|
|
|
|
Corn (Illinois)
|
$ 6.62/bushel
|
$ 6.64/bushel
|
$ (0.02)/bushel
|
(0.3
|
)%
|
|
Rendering
|
Bakery
|
Corporate
|
Total
|
||||||||
Decrease in finished product prices
|
$
|
(31.4
|
)
|
$
|
(0.3
|
)
|
$
|
—
|
|
$
|
(31.7
|
)
|
Decrease in raw material volume
|
(18.4
|
)
|
(3.5
|
)
|
—
|
|
(21.9
|
)
|
||||
Increase in other sales
|
0.5
|
|
0.3
|
|
—
|
|
0.8
|
|
||||
|
$
|
(49.3
|
)
|
$
|
(3.5
|
)
|
$
|
—
|
|
$
|
(52.8
|
)
|
|
Rendering
|
Bakery
|
Corporate
|
Total
|
||||||||
Increase/(decrease) in raw material costs
|
$
|
(20.4
|
)
|
$
|
1.8
|
|
$
|
—
|
|
$
|
(18.6
|
)
|
Decrease in raw material volume
|
(6.1
|
)
|
(1.7
|
)
|
—
|
|
(7.8
|
)
|
||||
Decrease in energy costs, primarily natural gas and diesel fuel
|
(2.4
|
)
|
(0.2
|
)
|
(0.2
|
)
|
(2.8
|
)
|
||||
Increase/(decrease) in other costs of sales
|
3.8
|
|
(0.3
|
)
|
0.8
|
|
4.3
|
|
||||
|
$
|
(25.1
|
)
|
$
|
(0.4
|
)
|
$
|
0.6
|
|
$
|
(24.9
|
)
|
|
Rendering
|
Bakery
|
Corporate
|
Total
|
||||||||
Increase in payroll and incentive-related benefits
|
$
|
0.7
|
|
$
|
0.1
|
|
$
|
2.5
|
|
$
|
3.3
|
|
Increase from prior year purchase accounting contingency
|
2.1
|
|
0.5
|
|
—
|
|
2.6
|
|
||||
Increase/(decrease) in other expense
|
—
|
|
(0.1
|
)
|
0.9
|
|
0.8
|
|
||||
|
$
|
2.8
|
|
$
|
0.5
|
|
$
|
3.4
|
|
$
|
6.7
|
|
•
|
As of
March 31, 2012
, the Company had availability of $
389.3 million
under the revolving loan facility, taking into account
no
outstanding borrowings and letters of credit issued of $
25.7 million
.
|
•
|
As of
March 31, 2012
, the Company has repaid all of the original $
300.0 million
term loan facility issued under the credit agreement. The amounts that have been repaid on the term loan may not be reborrowed.
|
•
|
The obligations under the Company's credit agreement are guaranteed by Darling National, Griffin, and its subsidiary, Craig Protein Division, Inc. and are secured by substantially all of the property of the Company.
|
•
|
The Notes are guaranteed on an unsecured basis by Darling's existing restricted subsidiaries, including Darling National, Griffin and all of its subsidiaries, other than Darling's foreign subsidiaries, its captive insurance subsidiary and any inactive subsidiary with nominal assets. The Notes rank equally in right of payment to any existing and future senior debt of Darling. The Notes will be effectively junior to existing and future secured debt of Darling and the guarantors, including debt under the Credit Agreement, to the extent of the value of assets securing such debt. The Notes will be structurally subordinated to all of the existing and future liabilities (including trade payables) of each of the subsidiaries of Darling that do not guarantee the Notes. The guarantees by the guarantors (the “Guarantees”) rank equally in right of payment to any existing and future senior indebtedness of the guarantors. The Guarantees will be effectively junior to existing and future secured debt of the guarantors including debt under the Credit Agreement, to the extent the value of the assets securing such debt. The Guarantees will be structurally subordinated to all of the existing and future liabilities (including trade payables) of each of the subsidiaries of each Guarantor that do not guarantee the Notes.
|
Senior Notes:
|
|
||
8.5% Senior Notes Due 2018
|
$
|
250,000
|
|
|
|
||
Senior Secured Credit Facilities:
|
|
||
Term Loan
|
$
|
—
|
|
Revolving Credit Facility:
|
|
||
Maximum availability
|
$
|
415,000
|
|
Borrowings outstanding
|
—
|
|
|
Letters of credit issued
|
25,652
|
|
|
Availability
|
$
|
389,348
|
|
|
31.1
|
Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, of Randall C. Stuewe, the Chief Executive Officer of the Company.
|
||
|
31.2
|
Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, of John O. Muse, the Chief Financial Officer of the Company.
|
||
|
32
|
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of Randall C. Stuewe, the Chief Executive Officer of the Company, and of John O. Muse, the Chief Financial Officer of the Company.
|
||
|
101
|
Interactive Data Files Pursuant to Rule 405 of Regulation S-T: (i) Consolidated Balance Sheets as of March 31, 2012 and December 31, 2011; (ii) Consolidated Statements of Operations for the three months ended March 31, 2012 and April 2, 2011; (iii) Consolidated Statements of Comprehensive Income for the three months ended March 31, 2012 and April 2, 2011; (iv) Consolidated Statements of Cash Flows for the three months ended March 31, 2012 and April 2, 2011; (v) Notes to the Consolidated Financial Statements
|
|
|
DARLING INTERNATIONAL INC.
|
|
|
|
|
|
|
|
|
|
Date:
|
May 10, 2012
|
By:
|
/s/ Randall C. Stuewe
|
|
|
|
Randall C. Stuewe
|
|
|
|
Chairman and
|
|
|
|
Chief Executive Officer
|
Date:
|
May 10, 2012
|
By:
|
/s/ John O. Muse
|
|
|
|
John O. Muse
|
|
|
|
Executive Vice President
|
|
|
|
Administration and Finance
|
|
|
|
(Principal Financial Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
Abbott Laboratories | ABT |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|